Monday, May 18, 2015 2:24:10 PM
All my posts, comments, and investments are not to be considered investment advice in any way.
Recent GLPG News
- Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings • GlobeNewswire Inc. • 03/28/2024 08:01:00 PM
- Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board • GlobeNewswire Inc. • 03/26/2024 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 11:41:59 AM
- Galapagos announces full year 2023 results and outlook for 2024 • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/16/2024 11:00:09 AM
- Galapagos presents at EBMT-EHA annual meeting 2024 • GlobeNewswire Inc. • 02/15/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:41:32 PM
- Galapagos completes transaction to transfer Jyseleca® business to Alfasigma • GlobeNewswire Inc. • 01/31/2024 09:01:00 PM
- Galapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer Drug • Dow Jones News • 01/04/2024 09:44:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 09:07:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 09:05:08 PM
- Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. • GlobeNewswire Inc. • 01/04/2024 09:01:00 PM
- BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets • PR Newswire (US) • 01/03/2024 09:01:00 PM
- Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology • GlobeNewswire Inc. • 01/03/2024 09:01:00 PM
- Galapagos signs agreement to transfer Jyseleca® business to Alfasigma • GlobeNewswire Inc. • 01/02/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/21/2023 09:03:59 PM
- Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301 • GlobeNewswire Inc. • 12/19/2023 09:01:00 PM
- Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101 • GlobeNewswire Inc. • 12/09/2023 05:00:00 PM
- Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023 • GlobeNewswire Inc. • 12/07/2023 09:01:00 PM
- Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care • PR Newswire (US) • 11/06/2023 12:45:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2023 12:26:11 PM
- Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023 • GlobeNewswire Inc. • 11/02/2023 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/02/2023 11:15:54 AM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM